Tag: Mediwound

Business

Mediwound Ltd (NASDAQ: MDWD) Obtains Complete Response Letter from U.S. FDA for NexoBrid Biologics Authorization Presentation

Mediwound Ltd (NASDAQ: MDWD) today announced it obtained a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) concerning the Biologics License Application (BLA). The company was looking for endorsement of NexoBrid® for eschar removal (debridement) in grownups with profound partial-thickness and full-thickness thermal burns.  FDA communicates […]